• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines

byAlex Xiang, MDandSimon Pan, MD
October 6, 2026
in Chronic Disease, Neurology, Pharma
Reading Time: 2 mins read
A woman experiencing a migraine, with visual representation of signaling pathways and a pill nearby, suggesting treatment with Rimegepant.
Share on FacebookShare on TwitterShare on LinkedIn

1. In adults with migraines unsuitable for triptans, rimegepant (Nurtec ODT) can provide rapid-onset and lasting symptom relief.

Evidence Rating Level: 1 (Excellent)

While triptans are a cornerstone of the acute treatment of migraine, there are numerous instances when their use is unsuitable, for example, when there is inadequate response, intolerability, or a contraindication. Calcitonin gene-related peptide receptor antagonists have been shown to be efficacious and safe in acute migraine management, with a recently randomized, placebo-controlled trial (NCT05509400) showing rimegepant to have significantly increased migraine pain relief. However, the full time course of rimegepant’s effect is unknown but important to establish, as quick onset of effect is commonly preferred by patients with migraine. The objective of the present study was to evaluate the full time course of rimegepant effect from 15 min to 48 hours post-dose based on data from NCT05509400. NCT05509400 was a phase 4, multinational, randomized, double-blind, placebo-controlled study that included adults 18 years and older with ≥ 1-year history of migraine attacks, migraine attacks lasting an average of 4–72 h if untreated, an average of 4–14 migraine days per month, and unsuitable for triptan use (intolerance (30.5%) and/or lack of efficacy (84.9%) to at least 2 triptans or the documented presence of a contraindication (9.1%)). 570 participants were randomized to rimegepant 75 mg (n = 286; mean [SD] age, 43.1 [11.8] years; 88.5% female) one dose or placebo (n = 284; mean [SD] age, 42.6 [11.5] years; 90.1% female). Participants recorded migraine headache pain intensity prior to dosing and at 15 min, 30 min, 45 min, 1 h, 1.5 h, 2 h, 3 h, 4 h, 6 h, 8 h, 24 h, and 48 h post-dose. Improvements of ≥ 5% for rimegepant over placebo with p ≤ 0.05 [difference (95% CI)] were first observed at 1 h for pain relief [8.6% (1.3%, 15.8%); p = 0.0201], and 1.5 h for pain freedom [6.2% (1.5%, 11.0%); p = 0.0103] and return to normal function [7.1% (1.1%, 13.1%); p = 0.0210]. Rimegepant significantly improved pain relief, pain freedom, and return to normal function at all subsequent time points, with significance remaining at 48 hours. These results suggest that in patients with migraines unsuitable for triptans, rimegepant can provide symptom relief within 1-2 hours that remains for up to 48 hours.

Click here to read this study in Neurology and Therapy

Image: PD

Citation: Lanteri-Minet M, Smith T, Nalpas C, Ramirez LM, Thiry A, McCollum S, et al. Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints from a Phase 4, Randomized, Double-Blind, Placebo-Controlled Study. Neurol Ther. 2026 Oct 3. doi: 10.1007/s40120-026-01043-6. Epub ahead of print. PMID: 42828704.

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers

Tags: migrainepainplaceborandomizedrimegepant
Previous Post

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

Next Post

Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions

RelatedReports

Asthma collage of a calm young man beside an engraved branching airway, an inhaler with a spacer and a sprig of grass pollen
Chronic Disease

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

November 21, 2026
Back CT scan collage: a ring-shaped CT scanner with its table, a stack of lower back vertebrae and a blank film sheet
All Specialties

Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers

November 21, 2026
Knee osteoarthritis collage: a calm older man with a gray beard, a knee joint inset with teal cartilage and a knee brace
Endocrinology

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

November 17, 2026
VATS collage: a pair of engraved lungs with a slim thoracoscope beside them, an incentive spirometer and a teal ribbon
Chronic Disease

Thoracic epidural and paravertebral blockade have similar efficacy for reduction of chronic post-thoracotomy pain

November 12, 2026
Next Post
A middle-aged man sitting in a chair appears alongside a magnifying glass over documents, suggesting an analysis related to medical assessment or triage for syncope.

Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions

A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

An illustration featuring silhouettes of healthcare workers and a hospital corridor, symbolizing the physician strike context in South Korea.

Physician edits to artificial intelligence (AI)-generated messages to patients were associated with different response time burdens

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.